Fortrea to Present at the Jefferies Global Healthcare Conference GlobeNewswire June 03, 2025 DURHAM, N.C., June 03, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Interim Chief Executive Officer, Peter M. Neupert and Chief Financial Officer, Jill McConnell will present at the Jefferies Global […]

(NASDAQ:WINT), WARRINGTON, Pa., June 03, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies for critical conditions and diseases, announced that its Board of Directors has agreed that the Company will create a cryptocurrency

(NasdaqGM:MRUS), UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics(R), Triclonics(R) and ADClonics(R)), today announced the launch of a proposed underwritten public offering of its common shares (the “Offer

(NASDAQ:ESEA), ATHENS, Greece, June 03, 2025 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today that it has secured a new time charter contract for its 4,250 teu intermediate containership, M/V Emmanuel P built in

(NASDAQ:NSPR), MIAMI, June 03, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard(TM) Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced the appointment of Michael Lawless, an industry veteran, as Chief Financial Officer, effective on or prior to June 30, 2025 (the “Effective

(NASDAQ:ANAB), Best-in-disease profile with JAK-like efficacy and monthly (Q4W) dosing in both three-month placebo-controlled and six-month​ blinded treatment period Favorable safety and tolerability, particularly when compared to standard of care biologics or JAKs Max response rates have not yet been observed; strict continuation criteria at three months in this Phase 2b trial excluded many patients

(NYSE:SB),(NYSE:SB-PC),(NYSE:SB-PD), MONACO, June 03, 2025 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company's 2024 Sustainability Report is available for download and can be accessed from its website using the link provided below. The 2024 Sustainability Report has been prepared in

(NasdaqGM:TELA), MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the European launch of OviTex Inguinal Reinforced Tissue Matrix, the only reinforced tissue matrix specifically engineered for laparoscopic and robotic-assisted inguinal hernia repair. This milestone follows the

(NASDAQ:SQFT),(NASDAQ:SQFTP),(NASDAQ:SQFTW), SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) — Presidio Property Trust, Inc. (“Presidio” or the “Company”) (NASDAQ: SQFT; SQFTP; SQFTW), an internally managed, diversified real estate investment trust (“REIT”), today announced that it has received formal notice from Nasdaq stating that the Company has regained compliance with the minimum bid price requirement set forth

(NasdaqGM:BRLT), SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) — Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in the upcoming 15th Annual East Coast IDEAS Investor Conference being held at The Westin Times Square in New